Contact
Please use this form to send email to PR contact of this press release:
ProQR Therapeutics Announces Transaction Completed for Théa to Acquire Sepofarsen and Ultevursen Ophthalmic Assets
TO:
Please use this form to send email to PR contact of this press release:
ProQR Therapeutics Announces Transaction Completed for Théa to Acquire Sepofarsen and Ultevursen Ophthalmic Assets
TO: